Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Cisplatin 75 / Gemcitabine 1250, Breast Cancer

Protocol-ID: 763 V1.1 (Mini), CISP75/GEMC1250, Breast Ca

Indication(s)

  • Breast Cancer (tripel negative); ICD-10 C50.-

Links

  • Efficacy of gemcitabine and cisplatin (GP) as first-line combination therapy in patients with triple-negative metastatic breast cancer: Preliminary results report of a phase II trial. [URL]
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 10.01.2023